11/14
05:27 pm
acon
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st [Yahoo! Finance]
Medium
Report
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st [Yahoo! Finance]
11/14
05:00 pm
acon
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Medium
Report
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
10/25
05:24 pm
acon
Aclarion files to sell 20M shares of common stocks by selling shareholders [Seeking Alpha]
Medium
Report
Aclarion files to sell 20M shares of common stocks by selling shareholders [Seeking Alpha]
10/10
07:00 am
acon
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Low
Report
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
9/27
07:18 am
acon
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes [Yahoo! Finance]
Low
Report
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes [Yahoo! Finance]
9/27
06:57 am
acon
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Medium
Report
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
9/13
08:30 am
acon
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
Medium
Report
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
9/12
07:07 am
acon
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones [Yahoo! Finance]
High
Report
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones [Yahoo! Finance]
9/12
06:57 am
acon
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
High
Report
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
9/10
07:09 am
acon
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial [Yahoo! Finance]
Low
Report
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial [Yahoo! Finance]
9/10
06:57 am
acon
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Medium
Report
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
9/6
11:27 am
acon
Aclarion Added to PRISM Emerging Medical Devices Index
Low
Report
Aclarion Added to PRISM Emerging Medical Devices Index
9/5
07:19 am
acon
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market [Yahoo! Finance]
Medium
Report
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market [Yahoo! Finance]
9/5
06:57 am
acon
Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market
High
Report
Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market
8/29
07:00 am
acon
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey [Yahoo! Finance]
Medium
Report
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey [Yahoo! Finance]
8/29
06:57 am
acon
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
High
Report
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
8/26
07:15 am
acon
Aclarion, Inc. (NASDAQ: ACON) had its "buy" rating re-affirmed by analysts at Ascendiant Capital Markets. They now have a $1.50 price target on the stock.
Medium
Report
Aclarion, Inc. (NASDAQ: ACON) had its "buy" rating re-affirmed by analysts at Ascendiant Capital Markets. They now have a $1.50 price target on the stock.
8/21
08:05 am
acon
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans [Yahoo! Finance]
Medium
Report
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans [Yahoo! Finance]
8/21
07:57 am
acon
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
Medium
Report
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
8/17
11:18 am
acon
Aclarion Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Medium
Report
Aclarion Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]